Log in

CNSX:VRTVeritas Pharma Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2,475 shs
Average Volume73,073 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Veritas Pharma Inc. focuses on the development of proprietary cannabis strains for chronic and acute pains, nausea and vomiting, and post-traumatic stress disorders. The company was formerly known as Seashore Organic Medicine Inc. and changed its name to Veritas Pharma Inc. in December 2015. Veritas Pharma Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive VRT News and Ratings via Email

Sign-up to receive the latest news and ratings for VRT and its competitors with MarketBeat's FREE daily newsletter.

Veritas Pharma (CNSX:VRT) Frequently Asked Questions

Has Veritas Pharma been receiving favorable news coverage?

Press coverage about VRT stock has trended extremely negative this week, according to InfoTrie. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Veritas Pharma earned a daily sentiment score of -4.6 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an effect on the stock's share price in the near term. View the latest news aboutVeritas Pharma.

Who are some of Veritas Pharma's key competitors?

What other stocks do shareholders of Veritas Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Veritas Pharma investors own include Surna (SRNA), CannTrust (CTST), Aurora Cannabis (ACBFF), MedReleaf (LEAF), Adobe (ADBE), Abattis Bioceuticals (ATT), Erie Indemnity (ERIE), EXACT Sciences (EXAS), First Trust Dow Jones Internet Index Fund (FDN) and IDEXX Laboratories (IDXX).

Who are Veritas Pharma's key executives?

Veritas Pharma's management team includes the following people:
  • Mr. Peter McFadden, Interim Pres, CEO & CFO
  • Ms. Barbara J. Joe, Controller
  • Mr. Blair C. Lowther, Corp. Sec. & Director

What is Veritas Pharma's stock symbol?

Veritas Pharma trades on the CNSX under the ticker symbol "VRT."

How do I buy shares of Veritas Pharma?

Shares of VRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Veritas Pharma's official website?

The official website for Veritas Pharma is www.veritaspharmainc.com.

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.